HOME >> BIOLOGY >> NEWS
Clinical trial shows timing of chemotherapy improves survival in breast cancer

New York, December 12, 2002 New research shows that giving doses of chemotherapy more frequently in time, leads to a significant improvement in survival with no increase in toxicity in women with node-positive breast cancer. The study, coordinated by the Cancer and Leukemia Group B (CALGB) for the National Cancer Institute's Breast Intergroup, found a 31 percent decrease in the death rate with more frequent chemotherapy administration, called "dose dense," compared to conventional treatment. The findings will be presented today at the 25th Annual San Antonio Breast Cancer Symposium.

"Since breast cancer is so common, and adjuvant drug therapy has already been found to be so effective, a way to make that treatment 31 percent more effective could potentially save thousands of lives per year in the United States alone," said Larry Norton, MD, Head of the Division of Solid Tumor Oncology at Memorial Sloan-Kettering Cancer Center, and senior author of the study.

A mathematical model called the Norton-Simon hypothesis formed the basis for the concept of dose density and another concept tested in this study, sequential therapy. The model, developed by Dr. Norton, and Richard Simon of the National Cancer Institute, was used to address the question: "Is it better to use a higher dose of a drug less often or a lower dose more frequently?" According to Dr. Norton, the answer depended upon the efficacy of the drugs and the pattern of growth of the disease, and could not be answered without a mathematical understanding of the underlying biology.

The study enrolled 2005 women with primary breast cancer that had spread to the lymph nodes, and with no other metastases. They were randomized post-operatively to one of four treatments. Two groups of patients were randomized to receive doxorubicin (A for Adriamycin), paclitaxel (T for Taxol), and cyclophosphamide (C for Cytoxan) sequentially, i.e., one at a time, in two- or three-week c
'"/>

Contact: Christine Hickey
media@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
12-Dec-2002


Page: 1 2 3

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Clinical judgement still counts strongly alongside genetic testing
3. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
4. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
5. DFG to establish seven new Clinical Research Units
6. Clinical trial patients dont care about study sponsors or physician conflicts of interest
7. NIH establishes Rare Diseases Clinical Research Network
8. Clinical study reports findings of combination therapy with DOXIL
9. Clinical study results published in NEJM show promising data on Antegren (natalizumab)
10. Clinical services must catch up
11. Clinical Advances towards the simplification if HIV therapy: First once-daily dosing results for the HIV protease inhibitor, Agenerase

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2020)... , ... May 26, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., ... receptor (TCR)-mimetic bispecific T cell engagers and TCR-based therapeutics, has implemented ...
(Date:5/21/2020)... ... May 19, 2020 , ... ... management solutions, today introduced BioMed to their award-winning computerized maintenance management system ... the people and systems around biomedical engineering to better allocate staff time, ...
(Date:5/21/2020)... ... 2020 , ... Agility Orthopedics, home to dedicated specialists providing ... pleased to announce a partnership with Dallas-based Simple Interact to further enhance the ... Agility Orthopedics is focused on speeding up patient workflows to enhance patient experience ...
Breaking Biology News(10 mins):
(Date:4/23/2020)... ... April 22, 2020 , ... ... healthcare providers to protect themselves from COVID-19. Virginia has only been receiving 50% ... Emergency Management Association (FEMA). , As Governor Northam told the Virginia Mercury, “While ...
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Research (SBIR) program to support the expansion of its digital health platform enabling ... conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government awards ...
(Date:4/1/2020)... ... 2020 , ... A joint venture between mobile health provider ... year to bring telehealth to various government agencies, has now focused its attention ... currently?awaiting an Emergency Use Authorization (EUA) waiver from the FDA?to?perform?AI?testing in the U.S. ...
(Date:3/27/2020)... ... March 25, 2020 , ... Enso ... centrally in the midwest for high-quality, quick-turn, board-certified reporting. In an effort ... independent, professional team that is focused on incredible quality, turnaround time and ...
Breaking Biology Technology:
Cached News: